EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases

Jin Qin, Wei Li, Lipin Yuan, Huiqin Liu, Rui Pang, Jiewen Zhang

Immunology Letters · 2025-06 · 273 · 106983

DOI: 10.1016/j.imlet.2025.106983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2025-06. Verfasst von Jin Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Myasthenia Gravis, Receptors, Fc, Autoimmune Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisReceptors, FcAutoimmune DiseasesHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedTreatment OutcomeQuality of LifeImmunoglobulin GYoung Adult

Stichwörter der Autor:innen

EfgartigimodEncephalitisIgGMyasthenia gravisNeurological autoimmune diseases

Substanzen

Receptors, FcImmunoglobulin G

Autor:innen und Institutionen

  • Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
  • Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China. Electronic address: zhangjiewen9900@126.com.

Zitieren

APA

Qin, J., Li, W., Yuan, L., Liu, H., Pang, R., & Zhang, J. (2025). Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases. Immunology Letters, 273, 106983. https://doi.org/10.1016/j.imlet.2025.106983

Vancouver

Qin J, Li W, Yuan L, Liu H, Pang R, Zhang J. Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases. Immunology Letters. 2025;273:106983. doi:10.1016/j.imlet.2025.106983

BibTeX
@article{Qin2025,
  author = {Qin, Jin and Li, Wei and Yuan, Lipin and Liu, Huiqin and Pang, Rui and Zhang, Jiewen},
  title = {Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases},
  journal = {Immunology Letters},
  year = {2025},
  volume = {273},
  pages = {106983},
  doi = {10.1016/j.imlet.2025.106983}
}
Kostenlos starten →